Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization - Wikidata - wikimedia - TriplyDB

Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization

Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization

http://www.wikidata.org/entity/Q34065098

about

Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives Assessment of response to therapy in hepatocellular carcinoma Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survival Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation.Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma.Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times.Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinoma Identifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non-three-dimensional Imaging Markers Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis.The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization.Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives.Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib.Assessment of the treatment response of HCC.Bridging and downstaging to transplantation in hepatocellular carcinoma.New concepts in embolotherapy of HCC.Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection.Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma.Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation.Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisation.Hepatocellular carcinomas within the Milan criteria: predictors of histologic necrosis after drug-eluting beads transarterial chemoembolization.Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis.Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery.Radiologic response to transcatheter hepatic arterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma.TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma.Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas

P2860

Q26852174-9E559AAE-D3EF-4C60-9E40-DF098F84E07D Q27023616-8911ACAB-3575-4EC6-92C3-A69ED521BB7B Q33560982-52EDA059-422F-4E16-96C7-1F0934BC70E3 Q33925521-DE53C152-911F-41D3-A751-80543C21C7D5 Q34165248-F24F4563-BFAB-4373-93DA-6C6EF03C8233 Q34680081-79AD093E-E352-4AA4-8257-AD0F5C30D4FF Q34982068-5EEFBE80-816A-4EEC-BC91-B600746E20D8 Q35051942-1E138A83-BFA0-438C-8F8F-573B85A1D1CB Q35085486-756609AC-7A49-4509-B99C-98AC71F67E66 Q35154103-D6146A18-BC2D-4D8A-8239-46302D765A44 Q35203257-5CB38C0C-CB80-4816-B3BF-0D78AA2A13DC Q35537007-177BBD1D-E1C2-41BD-B750-76EC1EFF6D37 Q35894925-C464F6DD-D8A3-48CF-952A-9F546C7E8403 Q36528048-F0C4132E-4EBC-4247-AE78-7D0C7CDD83DA Q37068157-18950D6C-A6A4-4B6E-94E9-D7243012108C Q37396802-CCFD518A-D46B-437B-9852-D736E90B1DD1 Q37833521-8BABEED7-3241-4540-9088-0C52299267EA Q38283671-D8073DAC-D340-4EA1-AE54-8C39AEE56B41 Q38904263-4C5D4A91-2512-49EE-8247-55806C7CC39F Q40091767-A5DE8DB5-5645-4C25-8DD5-7BBFA25B08D6 Q41235807-6B1EB4A4-7E00-40C7-B17D-8CD44B5B8CD1 Q42237455-D7EDA58C-96C6-4FA2-8F1E-F79EAD1F64BC Q46053397-E2176AEA-6A1F-44B2-8E50-47648D12512B Q46291005-B9A2F98E-9700-4A05-8FC6-F43024E5BC1B Q50218004-A68231F7-4C44-43B3-9AEC-6BC330E15D24 Q53167805-3487A5EA-2B98-4C52-993B-6257E6CF033B Q53321440-DA87D130-3A79-4086-AFB5-F66DA6DE827A Q53548617-5A09DFF7-CF25-4FC8-90F4-4824E9E43F5F Q56985915-48D3B1FB-1256-4CB0-8336-6864DF346357

P2860

Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization

http://www.wikidata.org/entity/Q34065098

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Radiologic-pathologic correlat ...... treated with chemoembolization

@ast

Radiologic-pathologic correlat ...... treated with chemoembolization

@en

Radiologic-pathologic correlat ...... treated with chemoembolization

@nl

type

label

Radiologic-pathologic correlat ...... treated with chemoembolization

@ast

Radiologic-pathologic correlat ...... treated with chemoembolization

@en

Radiologic-pathologic correlat ...... treated with chemoembolization

@nl

prefLabel

Radiologic-pathologic correlat ...... treated with chemoembolization

@ast

Radiologic-pathologic correlat ...... treated with chemoembolization

@en

Radiologic-pathologic correlat ...... treated with chemoembolization

@nl

P1433

Q34065098-DDE676DD-D3CC-47B8-ADFB-CD802A5DEA20

P1476

Q34065098-F942D74C-1C41-4DE5-974C-E65E4281356A

P2093

Q34065098-153E196F-4962-44F5-A285-57C05CCDC0B3

Q34065098-21798614-5586-409F-9BBA-FB0348655BF8

Q34065098-3B7AA657-F4FC-4CE8-B9EA-509F414F61BB

Q34065098-7DA49784-2A9F-4F48-8781-E60EFB99C0C5

Q34065098-AEFC79FD-AC03-4443-9E29-C949DB0DB2C7

Q34065098-B1703AC4-114B-4F30-B2BE-12D934CA1A52

Q34065098-C7EFC181-6D20-4FCD-B784-6A970D6FAB9F

Q34065098-D462AEA6-44B6-4FAE-85D1-D8429577A604

Q34065098-DF459C43-DB9D-46EE-B882-B336BF58118D

Q34065098-F3477592-6140-48AD-B425-CAEA056943C7

P2860

Q34065098-2EE3EA18-7380-4B50-9CD8-1B70B1290C5F

Q34065098-44B896B7-A7F2-449B-BEAB-5E821D3D3F6D

Q34065098-482C27B3-12A4-4532-B6FC-73B77F16B1C1

Q34065098-4D5F6DF1-EE01-43EB-BB77-0866C8E41A80

Q34065098-5EE80FAF-2725-4FC4-83D0-F9BE02D8B682

Q34065098-7C129E43-CBD2-4183-8EE9-047B0932AE4F

Q34065098-819A6202-B470-4775-8C2A-1F2846D2A535

Q34065098-8A1336A2-4D48-4CFA-A1E3-4B53B877361A

Q34065098-8B34563A-A9E5-44D2-B9AD-EC60011EF88A

Q34065098-8CE9EBC1-2DC2-42C9-8EE5-5956A0206A9A

P2888

Q34065098-CF7BCBC9-5439-479A-ACB5-67FB0C419F20

P304

Q34065098-07033198-C8C1-410F-9590-5A9BBB6A68CD

P31

Q34065098-7FAF2883-9DD5-42FB-941D-21EF05BC7896

P356

Q34065098-8CAD3B7D-126E-49E1-82DA-B4A3F45FD604

P433

Q34065098-99204EC1-BAE9-481D-A167-E0C7F17C71F7

P478

Q34065098-56227B05-7C24-4AE6-8AC8-A41E9B4361C2

P50

Q34065098-0617C1F1-D4A0-425B-A9CB-CD0E6118C42A

Q34065098-0FFDCDC0-5413-41D3-8EA6-008431A35DC8

Q34065098-64167AD5-1D9B-4B12-AB46-40CF8D038F17

P577

Q34065098-DBFA4428-523C-4CD0-BF8B-DBC56D499988

P5875

Q34065098-0017C318-4A52-4145-8DF8-ED817849A27D

P6179

Q34065098-F20D9DD6-7510-4F74-9C5C-7AADCF9AD42B

P698

Q34065098-42B3FB5D-6FB7-41D9-AAAC-29F9BB636F7C

P932

Q34065098-03ABB5FA-FE0C-477E-98A8-23AF9C090455

P356

S00270-009-9766-5

P1433

CardioVascular and Interventional Radiology

P1476

Radiologic-pathologic correlat ...... treated with chemoembolization

@en

P2093

Ed Wang

http://www.w3.org/2001/XMLSchema#string

Frank H Miller

http://www.w3.org/2001/XMLSchema#string

Kent T Sato

http://www.w3.org/2001/XMLSchema#string

Laura Kulik

http://www.w3.org/2001/XMLSchema#string

Mary F Mulcahy

http://www.w3.org/2001/XMLSchema#string

Michael Abecassis

http://www.w3.org/2001/XMLSchema#string

Reed A Omary

http://www.w3.org/2001/XMLSchema#string

Ritu Nayar

http://www.w3.org/2001/XMLSchema#string

Robert J Lewandowski

http://www.w3.org/2001/XMLSchema#string

Robert K Ryu

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Hepatocellular carcinoma and hepatitis C in the United States.

Chemoembolization for hepatocellular carcinoma.

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.

The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.

P2888

s00270-009-9766-5

P304

1143-1152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00270-009-9766-5

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Vanessa L. Gates

P577

2009-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40454288

http://www.w3.org/2001/XMLSchema#string

P6179

1011355349

http://www.w3.org/2001/XMLSchema#string

P698

19967371

http://www.w3.org/2001/XMLSchema#string

P932

2921465

http://www.w3.org/2001/XMLSchema#string